ArticleVaccines2022

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose.

Nesrin Gareayaghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.